Seattle-Physician Micro Systems, Inc. has released Web View, a featureallowing information contained in the company's Practice Partner PatientRecords and Appointment Scheduler to be viewed via the Internet.
Vobramitamab duocarmazine continues to show promise in mCRPC
May 10th 2024Updated data from the phase 2 TAMARCK study continued to show safety and preliminary efficacy with the B7-H3–targeting antibody-drug conjugate vobramitamab duocarmazine in patients with metastatic castration-resistant prostate cancer.